With engineered T-cell therapies becoming more widely used to treat malignancies, including Hepatitis B virus-induced liver ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...

AI-human collaboration in a "Virtual Lab" successfully designs and experimentally validates nanobodies with enhanced binding ...

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

While countless long COVID sufferers put Pretorius’s theory to the test, her new focus is raising its awareness. Not only ...

1, KP.3, KP.3.1.1, and LB.1. PEMGARDA targets the SARS-CoV-2 spike protein receptor binding domain (RBD), thereby inhibiting virus attachment to the human ACE2 receptor on host cells. PEMGARDA ...

According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

Most cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they ...

Croatia’s health minister and several others were detained on Friday on suspicion of corruption as part of an investigation ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.